These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31638255)

  • 1. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
    Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
    Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4.
    Bi R; Deng Y; Tang C; Xuan L; Xu B; Du Y; Wang C; Wei W
    Oncol Rep; 2020 Nov; 44(5):1939-1948. PubMed ID: 33000263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway.
    Cha Z; Cheng J; Xiang H; Qin J; He Y; Peng Z; Jia J; Yu H
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):719-728. PubMed ID: 31281953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
    Kim B; Seo JH; Lee KY; Park B
    Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5.
    Chen Y; Wei L; Zhang X; Liu X; Chen Y; Zhang S; Zhou L; Li Q; Pan Q; Zhao S; Liu H
    Oncol Rep; 2018 Nov; 40(5):2435-2444. PubMed ID: 30132536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline.
    Zinnah KMA; Park SY
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis.
    Lee DH; Kim DW; Lee HC; Lee JH; Lee TH
    Biochem Biophys Res Commun; 2014 Apr; 446(4):815-21. PubMed ID: 24491546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.
    Siegelin MD; Siegelin Y; Habel A; Rami A; Gaiser T
    Neurobiol Dis; 2009 May; 34(2):259-66. PubMed ID: 19385057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL of Hope Meeting Resistance in Cancer.
    Deng D; Shah K
    Trends Cancer; 2020 Dec; 6(12):989-1001. PubMed ID: 32718904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L; Wang Y; Zheng H; Zhang D; Wu X; Sun G; Yang T
    J Chemother; 2017 Jun; 29(3):179-188. PubMed ID: 28067150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
    Jane EP; Premkumar DR; Pollack IF
    Mol Cancer Ther; 2011 Jan; 10(1):198-208. PubMed ID: 21220502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.
    Liu PC; Lu G; Deng Y; Wang CD; Su XW; Zhou JY; Chan TM; Hu X; Poon WS
    PLoS One; 2017; 12(1):e0171157. PubMed ID: 28135339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY; Kim EH; Kim SU; Kwon TK; Choi KS
    Carcinogenesis; 2010 Mar; 31(3):367-75. PubMed ID: 19939880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
    Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
    Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
    James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
    Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
    Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
    PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.
    Yulyana Y; Tovmasyan A; Ho IA; Sia KC; Newman JP; Ng WH; Guo CM; Hui KM; Batinic-Haberle I; Lam PY
    Stem Cell Rev Rep; 2016 Feb; 12(1):140-55. PubMed ID: 26454429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NVP-BKM120 potentiates apoptosis in tumor necrosis factor-related apoptosis-inducing ligand-resistant glioma cell lines via upregulation of Noxa and death receptor 5.
    Foster KA; Jane EP; Premkumar DR; Morales A; Pollack IF
    Int J Oncol; 2015 Aug; 47(2):506-16. PubMed ID: 26044191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ
    Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.